Form 4: ALUMIS Chief Legal Officer Acquires 100,000 Stock Options Under Equity Plan
Insider Transaction Report
ALUMIS Inc.'s Chief Legal Officer, Sanam Pangali, acquired 100,000 stock options with an exercise price of $3.56, set to vest over four years.
Summary
- Sanam Pangali, Chief Legal Officer of ALUMIS Inc. (ALMS), acquired 100,000 stock options.
- The options have an exercise price of $3.56 per share.
- The transaction date for the acquisition was July 10, 2025.
- The options are for Common Stock, with 100,000 shares underlying the options.
- The options expire on July 9, 2036.
- The vesting schedule for these options is 25% on July 4, 2026, with the remaining 75% vesting in equal monthly installments over the subsequent 36 months, contingent on continuous service as defined in the Issuer's 2024 Equity Incentive Plan.
- The transaction was made pursuant to a Rule 10b5-1(c) plan.
Sentiment
Score: 7
Explanation: The acquisition of stock options by a key executive is generally a positive signal, indicating alignment of interests and long-term commitment. It's a standard compensation event, not indicative of immediate financial distress or exceptional performance, hence a neutral-to-positive score.
Positives
- Acquisition of stock options by a key executive (Chief Legal Officer) indicates alignment of interests with shareholders.
- The transaction was executed under a Rule 10b5-1(c) plan, suggesting a pre-planned and compliant acquisition.
- The long expiration date of July 9, 2036, provides a significant window for the options to become in-the-money.
Negatives
- No immediate cash inflow for the executive, as these are options, not shares.
- The vesting schedule extends over several years, tying the executive's compensation to long-term performance and retention.
Risks
- The value of the stock options is dependent on the future performance of ALUMIS Inc.'s common stock. If the stock price does not rise above the exercise price of $3.56, the options may expire worthless.
- The vesting is subject to the Reporting Person's Continuous Service, meaning the options could be forfeited if employment ceases before full vesting.
Future Outlook
The acquisition of stock options by a key executive suggests a long-term commitment to the company's future performance, as the value of these options is directly tied to the appreciation of ALUMIS Inc.'s stock price over the vesting and exercise period.
Industry Context
This is a standard executive compensation event. It aligns the interests of the Chief Legal Officer with shareholders, a common practice in industries like biotech/pharma, which often utilize equity incentive plans to retain key talent and incentivize long-term performance.
Comparison to Industry Standards
- Granting stock options to key executives like the Chief Legal Officer is a common compensation practice across various industries, including biotechnology and technology, to incentivize long-term performance and align executive interests with shareholder value.
- The vesting schedule of 25% after one year and monthly thereafter for three years is a standard four-year vesting period, comparable to equity grants at companies like Moderna, Pfizer, or smaller biotech firms, which often use similar structures to retain talent and encourage sustained contributions.
- The exercise price being fixed at the grant date's market price (implied by a typical option grant) is also standard.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan Utilization | The stock option grant was made under the Issuer's 2024 Equity Incentive Plan, indicating the company is utilizing its approved equity compensation framework. | 07/10/2025 | Reinforces the company's commitment to performance-based compensation and executive retention through established governance mechanisms. |
Stakeholder Impact
- Shareholders: The grant aligns the Chief Legal Officer's financial interests with shareholder value creation, as the options gain value only if the stock price increases. It also represents potential future dilution if exercised, which is typical for equity compensation plans.
- Employees: This grant is part of the company's overall compensation strategy, which can influence employee morale and retention, particularly for key executives.
Next Steps
- Sanam Pangali will continue to hold the stock options, subject to the vesting schedule.
- The options will vest over the next four years, with the first 25% vesting on July 4, 2026.
- Sanam Pangali may choose to exercise the options at any point after vesting and before the expiration date of July 9, 2036, assuming the stock price is above the exercise price.
Key Dates
| Date | Description |
|---|---|
| 07/10/2025 | Date of earliest transaction for the stock option acquisition. |
| 07/14/2025 | Date the Form 4 filing was signed. |
| 07/04/2026 | First vesting date for 25% of the acquired stock options. |
| 07/09/2036 | Expiration date of the acquired stock options. |
Recommendation
holdKeywords
ALUMIS Inc., ALMS, Stock Options, Form 4, Insider Trading, Executive Compensation, Sanam Pangali, Chief Legal Officer, Equity Incentive Plan, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.